Iterum Therapeutics plc (ITRMF) Shares Outstanding (2017 - 2025)

Iterum Therapeutics has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $49.0 million in Q3 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 144.42% year-over-year to $49.0 million in Q3 2025; TTM through Sep 2025 was $49.0 million, a 144.42% increase from a year earlier, with the FY2024 full-year figure at $19.7 million, up 51.97% from the prior year.
• Shares Outstanding (Entity) was $49.0 million for Q3 2025 at Iterum Therapeutics, up from $44.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $182.8 million in Q2 2021, with the low at $12.2 million in Q3 2021.
• Average Shares Outstanding (Entity) over 5 years is $33.5 million, with a median of $13.1 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) surged 1070.53% in 2021, then tumbled 93.31% in 2022.
• Over 5 years, Shares Outstanding (Entity) stood at $12.2 million in 2021, then climbed by 4.28% to $12.7 million in 2022, then gained by 2.02% to $13.0 million in 2023, then surged by 51.97% to $19.7 million in 2024, then jumped by 148.7% to $49.0 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $49.0 million (Q3 2025), $44.7 million (Q2 2025), and $40.0 million (Q1 2025), per Business Quant data.